In breakthrough research, a novel molecule has shown promise in lab tests as a potential preventive against variants of the SARS-CoV-2 virus. Developed by the Department of Chemistry team, Shiv Nadar IoE, and Paris Cité University in France, the molecules can potentially treat the acute and long-term symptoms of COVID-19.
Dr. Subhabrata Sen. PhD, FRSC, Professor at the Department of Chemistry, Shiv Nadar IoE, and the corresponding author of the study, which has been published in the European Journal of Medicinal Chemistry, says, 'They are first-in-class molecules displaying the original property of targeting not only one, but several molecular targets involved in COVID-19.'